The mineralocorticoid receptor antagonist did not reduce primary outcomes in the CLEAR SYNERGY trial, but there was a suggestion that it did prevent new or worsening heart failure.

New research found that the medication spironolactone, often prescribed for hypertension (high blood pressure), may reduce the risk of heart failure in people recovering from a heart attack.

Over 2 decades ago, the aldosterone antagonist eplerenone proved beneficial after MI complicated by left ventricular ...

Part 2 of this 7,000-patient trial suffered from discontinuations and low event rates: still, early MRAs did not impact CV ...

A recent study from the University of Bristol offers new hope for people with diabetes, who are at a high risk of kidney ...

Diabetes doesn’t just impact blood sugar; it often leads to serious kidney issues, too. In fact, about 40% of people with diabetes develop a condition known as diabetic kidney disease. In the UK, ...

He has since said his weight loss was down to better diet and exercise, having tried the weight loss drug Ozempic and not enjoyed it. There is no denying that he has looked – and sounded ...

“If I’m given another chance, I’ll wipe all of you,” Duterte, 79, who is seeking a new term as mayor of his southern home city of Davao next year, said of drug dealers and criminal ...

Copyright 2024 The Associated Press. All Rights Reserved. Former Philippine President Rodrigo Duterte gestures during a Senate investigation on the war on the drugs ...

Iambic, which has previously won investment from tech giant Nvidia (NVDA.O), opens new tab, published details of its new AI drug discovery model, named "Enchant". Enchant was trained on large ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.